News
Berlin Appoints Bayer and Charité as the new “Zukunftsort” (Future Site)
Berlin has officially designated the
The new innovation district connects leading research, clinical expertise, and industry along the full health‑innovation value chain, creating ideal conditions for advancing cutting‑edge therapies from research into practice.
As part of this future location, the Berlin‑Mitte health innovation ecosystem further reinforces Berlin’s international visibility and attractiveness in fields such as personalized, gene‑ and cell‑based medicine.
New white paper highlights Europe's potential in developing innovative therapies
The Oslo Cancer Cluster, in collaboration with the Berlin Centre for Gene and Cell Therapies, has published a new white paper entitled “Bridging the Gaps: Unlocking the Future of Advanced Therapies in Europe via Novel Alliances”